Description
Anti-CD11a (Efalizumab), Human IgG1 Antibodyis available at Gentaur for Next week Delivery.
Description: Integrin alpha-L/beta-2 is a receptor for ICAM1, ICAM2, ICAM3 and ICAM4. It is involved in a variety of immune phenomena including leukocyte-endothelial cell interaction, cytotoxic T-cell mediated killing, and antibody dependent killing by granulocytes and monocytes.
Immunogen Sequence:Efalizumab binds to CD11a, a subunit of leukocyte function antigen-1 (LFA-1), which is expressed on all leukocytes.
Target Alternative Name:LFA-1; integrin alpha L
Species Reactivities:Human
Tag Line:Monoclonal antibody to detect CD11a in human samples.
Formulation:200 µg affinity purified human antibody in phosphate-buffered saline (PBS) containing 0.02% Proclin 300
Purification: Affinity purified using protein A
Application:/
Positive Control:N/A
Application And Usages:/
Handling:The antibody solution should be gently mixed before use
Additional Information
| Size: | 200 µg | 
| Antibody Target: | ITGAL | 
| Category: | Immunology | 
| Host: | Recombinant | 
| Antibody Type: | Monoclonal | 
| Isotype: | Human IgG1, kappa | 
| Accession Number: | P20701 | 
| Gene Id: | 3683 | 
| Appearance: | Colorless liquid | 
| Form: | Liquid | 
| Storage Condition: | -20°C | 
| Shipping Condition: | gel pack | 
| Shelf Life: | 12 months | 
| Country of Animal Origin: | USA | 
| Country of Manufacture: | USA | 
| Usage: | For Research Use Only! Not to be used in humans | 
| Western Blot Verified: | Not Verified | 
| Immunocytochemistry Verified: | Not Verified | 
| Immunofluorescence Verified: | Not Verified | 
| Immunoprecipitation Verified: | Not Verified | 
| FACS Verified: | Not Verified | 
| ELISA Verified: | Not Verified | 
| ChIP Verified: | Not Verified | 
| Dot Blot Verified: | Not Verified | 
| Flow Cytometry Verified: | Not Verified | 
 
             
             
                                 
                                 
             
            